Skip to main content
. 2011 Sep 7;2011(9):CD006165. doi: 10.1002/14651858.CD006165.pub3

Palmer 2000.

Trial name or title Rosiglitazone intervention study on patients with type 1.5 diabetes
Methods Randomised controlled trial
Participants Antibody positive T2 diabetes, aged 35 to 69 years, no history of ketonuria.
Interventions Rosiglitazone or glyburide (SU)
Outcomes Fasting and stimulated C peptide, Antibody levels
Starting date 2000
Contact information Jerry Palmer, Seattle Institute for Biomedical and Clinical Research, University of Washington.
Notes